Daniel Virnich

Companies

• Starling Oncology, Inc.Chief executive officer Nov 16, 2023 to now¹
• Starling Oncology, Inc.President Mar 23, 2022 to Mar 21, 2023²
• Starling Oncology, Inc.Chief operating officer Nov 16, 2021 to Nov 16, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SOStarling Oncology, Inc. STLN2,337,166 shares⁴$15.3M at $6.53May 21, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 21, 2026Other 23,058 shares at $4.47 of Starling Oncology, Inc.⁴
• Mar 27, 2026Other 98,534 shares at $3.07 of Starling Oncology, Inc.⁵
• Mar 27, 2026Granted 670,608 shares of Starling Oncology, Inc.⁵
• Mar 17, 2026Other 11,834 shares at $3.59 of Starling Oncology, Inc.⁶
• Nov 17, 2025Granted 6,464 shares of Starling Oncology, Inc.⁷
• Nov 12, 2025Granted 6,211 shares of Starling Oncology, Inc.⁸
• May 21, 2025Returned to company 20,388 shares at $2.68 of Starling Oncology, Inc.⁹
• Mar 31, 2025Granted 1,083,334 shares of Starling Oncology, Inc.¹⁰
• Mar 26, 2025Bought 22,640 shares at $1.04 of Starling Oncology, Inc.¹¹
• Mar 19, 2025Returned to company 10,261 shares at $0.89 of Starling Oncology, Inc.¹²
• Nov 20, 2024Returned to company 4,977 shares at $0.14 of Starling Oncology, Inc.¹³
• Nov 20, 2024Returned to company 4,750 shares at $0.14 of Starling Oncology, Inc.¹³
• Nov 12, 2024Other 117,142 shares of Starling Oncology, Inc.¹⁴
• Nov 12, 2024Other 78,094 shares of Starling Oncology, Inc.¹⁴
• May 21, 2024Granted 198,517 shares of Starling Oncology, Inc.¹⁵
• May 21, 2024Returned to company 11,173 shares at $0.60 of Starling Oncology, Inc.¹⁵
• Nov 21, 2023Returned to company 4,322 shares at $2.19 of Starling Oncology, Inc.¹⁶
• Nov 14, 2023Returned to company 4,604 shares at $2.39 of Starling Oncology, Inc.¹⁷
• Mar 17, 2023Granted 114,944 shares of Starling Oncology, Inc.¹⁸
• Dec 7, 2022Exercised options 175,000 shares at $0.86 of Starling Oncology, Inc.¹⁹
• Dec 7, 2022Exercised options 175,000 shares at $0.86 of Starling Oncology, Inc.¹⁹
• Nov 17, 2022Granted 40,101 shares of Starling Oncology, Inc.²⁰
• Nov 15, 2022Sold 3,767 shares at $2.03 of Starling Oncology, Inc.²¹
• Nov 15, 2022Returned to company 3,767 shares at $2.03 of Starling Oncology, Inc.²²
• Mar 21, 2022Granted 42,015 shares of Starling Oncology, Inc.²³